Exosomes from bone marrow mesenchymal stem cells promoted osteogenic differentiation by delivering miR-196a that targeted Dkk1 to activate Wnt/β-catenin pathway CURRENT STATUS: UNDER REVIEW

Background: Osteoporosis is the most common bone metabolic disease. Emerging evidence suggests that exosomes are secreted by diverse cells such as bone marrow mesenchymal stem cells (BMSCs), and play important role in cell-to-cell communication and tissue homeostasis. Recently, the discovery of exosomes has attracted attention in the field of bone remodeling. Methods: The exosomes were extracted from BMSCs and labeled by PKH-67, and then incubated with hFOB1.19 cells to investigate the miR-196a function on the osteoblast differentiation of hFOB1.19. The osteoblast differentiation was detected via alizarin red staining and the expression of osteoblast genes were detected by western blot. The cell apoptosis was detected by flow cytometer. The target relationship of miR-196a and Dickkopf-1 (Dkk1) were verified by luciferase assay and western blot. Results: Here we demonstrated that exosomes extracted from BMSCs (BMSC-exo) significantly promoted hFOB1.19 differentiation to osteoblasts. We found that BMSC-exo were enriched with miR-196a and delivered miR-196a to hFOB1.19 cells to inhibit its target Dkk1, which is a negative regulator of Wnt/ β-catenin pathway. Conclusion: BMSC-exo activated Wnt/β-catenin pathway to promote osteogenic differentiation, while BMSC-exo failed to exert the effects when miR-196a was deprived. In conclusion, miR-196a delivered by exosomes from BMSCs plays an essential role in enhancing osteoblastic differentiation by targeting Dkk1 to activate Wnt/β-catenin pathway.

Exosomes from bone marrow mesenchymal stem cells promoted osteogenic differentiation by delivering miR-196a that targeted Dkk1 to activate Wnt/β-catenin pathway

Introduction
Osteoporosis (OP) is a systematic bone disease characterized by bone loss, imbalance of bone metabolism and destruction of trabecular microstructure, and is the most common geriatric disease, especially in postmenopausal women [1] . Several studies have confirmed that bone healing in osteoporotic women and osteoporotic animals is remarkably delayed [2,3] . In the past few years, a variety of strategies have been developed to treat osteoporotic defects, such as autologous bone transplantation, allogeneic bone transplantation, and the combination of scaffold materials with growth factors or cells, but the efficacy is not satisfactory.
Bone remodeling consists of two processes, osteoblast mediated bone formation and osteoclast mediated bone resorption. Once the homeostasis of bone remodeling is broken, bone diseases such as osteoporosis will develop. Bone marrow mesenchymal stem cells (BMSCs) are regarded as promising seed cells in tissue engineering due to easy accessibility and multipotent ability to differentiate into adipocyte, osteoblast, cardiomyocytes, and neurons. Recently, emerging evidence has demonstrated that the cross-talk between monocyte-macrophage-osteoclasts and osteoblasts plays a vital role in the pathology of osteoporosis [4,5] . Osteoblasts could be differentiated from BMSCs, and such a process is finely regulated by several transcription factors [6] . A series of bonederived regulators responsible for the cross-talk have already been identified, such as transforming growth factor-β (TGF-β), bone morphogenetic protein-9 (BMP-9), runt-related transcription factor − 2 (Runx2), Osterix (Osx), and alkaline phosphatase (ALP) [7,8] . Therefore, further understanding of the mechanism underlying osteogenic differentiation is crucial for the development of therapeutic approaches for osteoporosis.
Interestingly, bone remodeling is regulated by the factors packaged in lipid bilayered membrane vesicles called exosomes [9,10] . Exosome, as an important part of the microenvironment, is a membrane vesicle secreted by numerous types of cells with 40-150 nm in diameter, such as dendritic cells, reticulocytes, tumor cells, B cells, T cells, mast cells, epithelial cells, and BMSCs [11,12] .
Prevailing evidences revealed that exosomes play pivotal role in cell communication to regulate the function and differentiation of homogeneous and heterogeneous recipient cells by transferring biologically active molecules, such as proteins, lipids, mRNA, microRNAs (miRNAs) [5,13] . Earlier studies based on animal models have suggested that local transplantation of BMSCs promoted bone regeneration [14] . BMSCs actively produce exosomes, and BMSC-conditioned medium potently stimulates bone regeneration [15] . However, the potential role and underlying mechanisms of BMSCderived exosomes (BMSC-exo) in bone regeneration have not been fully elucidated.
Qin et al. [13] compared the miRNAs in BMSCs and its exosomes by RNA sequencing, and found that three osteogenic-related miRNAs including miR-196a, miR-27a and miR-206 were highly enriched in BMSC-exo. Notably, miR-196a has been identified to promote pancreatic cancer cell proliferation [16] .
However, there are few reports about the role of miR-196a in the occurrence and development of osteoporosis.
In this study, we presented in vitro evidence to demonstrate that BMSC-exo could enter osteoblasts to promote osteoblastic differentiation. Moreover, we found that miR-196a was a key exosomal component to promote osteoblastic differentiation via targeting Dickkopf-1 (Dkk1) which is a known negative regulator of Wnt/β-catenin pathway.

Statistical analysis
Data were expressed as mean ± standard deviation (SD), and analyzed with Graph-Pad Prism 5.0 software (GraphPad Software, San Diego, CA). Statistical analyses were performed using one-way ANOVA, followed by Turkey's post-test. Differences with p < 0.05 were considered statistically significant.

Dkk1 knockdown promoted osteoblast differentiation
To investigate the role of Dkk1 in osteoblast differentiation, si-Dkk1 was transfected into BMSCs and the exosomes were extracted. The expression of Dkk1 was detected by Western blot analysis (Fig. 5A,   B). In the exosomes extracted from BMSCs transfected by si-Dkk1, Dkk1 expression was significantly suppressed (p < 0.05). Alizarin red staining showed that when Dkk1 suppressed exosomes were taken by HFOB1.19 cells, osteoblast differentiation increased compared with cells treated by BMSCsexosomes (Fig. 5C). The expression of osteoblast induction related proteins such as RUNX2, ALP, OCN and OPN showed the same trend (p < 0.05) (Fig. 5D).
3.5 BMSCs-exo targeted Dkk1 to activate Wnt/β-catenin pathway in hFOB1.19 cells Wnt/β-catenin pathway play a key role in osteoblast differentiation, Dkk1 as a negative regulator of this pathway has been confirmed to be a direct target of miR-196a. Therefore, we detected the levels of Dkk1 and other components of Wnt/β-catenin pathways in hFOB1.19 cells by Western blot analysis (Fig. 6A). Densitometry analysis showed that Dkk1 levels decreased significantly in cells treated with BMSCs-exosomes compared to control cells, and further decreased in cells treated with miR196a mimic (Fig. 6B). Consistently, Wnt, Dvl, β-catenin levels increased significantly while p-GSK3β levels decreased significantly in cells treated with BMSCs-exosomes and miR196a mimic compared to control cells (Fig. 6C). Collectively, these results indicated that BMSCs-exo targeted Dkk1 to activate Wnt/β-catenin pathway.

Discussion
Osteoporosis is a metabolic bone disease characterized by decreased bone mass and microstructural destruction of bone tissue, resulting in increased bone fragility and fracture. [18] The proliferation and differentiation of BMSCs are closely related to bone metabolism. One aspect of osteoporosis is low potential of osteoblast differentiation [19] .
The growing evidence has revealed that miRNAs play important role in osteoblast differentiation. Kim et al. [20] found that miR-196a positively regulated osteoblast differentiation but the mechanism remained unclear. Exosomes can directly transfer various bioactive molecules including mRNAs, microRNAs and proteins from donate cells to recipient cells. In this study we found that BMSC-exo can be taken by recipient hFOB1.19 cells, and osteoblast differentiation of hFOB1.19 was promoted by BMSC-exo. Moreover, osteoblast differentiation was enhanced when miR-196a enriched BSMCs-exo was taken up, but was antagonized when miR-196a was deprived. Therefore, miR-196a as one of the osteoblast-related miRNAs found enriched in BMSC-exo [13] , may play an indispensable role in osteoblast differentiation. Moreover, we found that miR-196a directly inhibited the expression of its target Dkk1, a known negative regulator of Wnt/β-catenin pathway [21,22] .
Osteoblast differentiation involves multiple signaling pathways. Wnt signaling participates in cell proliferation, differentiation, migration, apoptosis to maintain the dynamic balance of cells [23,24]

Consent for publication
Not applicable

Availability of data and materials
Not applicable      (C) Densitometry analysis of Wnt, Dvl, GSK3β, p-GSK3β and β-catenin levels. Data were mean ± SD. n = 6. *, P< 0.05, compared to sham group